PEN

Penumbra, Inc.

335.12

USD

PEN Earnings Reports

Positive Surprise Ratio

PEN beat 35 of 41 last estimates.

85%

Next Report

Date of Next Report

Apr 21, 2026

Estimate for Q1 26 (Revenue/ EPS)

$374.82M

$1.08

Implied change from Q4 25 (Revenue/ EPS)

-2.74%

-8.47%

Implied change from Q1 25 (Revenue/ EPS)

+15.63%

+30.12%

Penumbra, Inc. earnings per share and revenue

On Feb 25, 2026, PEN reported earnings of 1.18 USD per share (EPS) for Q4 25, beating the estimate of 1.12 USD, resulting in a 5.02% surprise. Revenue reached 385.38 million, compared to an expected 370.46 million, with a 4.03% difference. The market reacted with a +0.08% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 17 analysts forecast an EPS of 1.08 USD, with revenue projected to reach 374.82 million USD, implying an decrease of -8.47% EPS, and decrease of -2.74% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

ClearPoint Neuro, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.20

Actual

-$0.26

Surprise

-27.45%

EDAP TMS SA

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.13

Actual

-$0.21

Surprise

-65.56%

Hyperfine, Inc. Class A Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.05

Surprise

+38.73%

Neuronetics, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.10

Surprise

+8.09%

InspireMD, Inc.

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.14

Surprise

+29.01%

DarioHealth Corp. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$3.30

Actual

-$3.43

Surprise

-3.71%

Spectral AI, Inc. Class A Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.12

Actual

-$0.11

Surprise

+14.86%

SiNtx Technologies, Inc. Common Stock

Report Date

Mar 20, 2026 For Q4 25

Estimate

-$0.56

Actual

-$0.56

Surprise

-1.60%

Tenon Medical, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.36

Actual

-$0.38

Surprise

-3.49%

FAQ

What were Penumbra, Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Penumbra, Inc. reported EPS of $1.18, beating estimates by 5.02%, and revenue of $385.38M, 4.03% above expectations.

How did the market react to Penumbra, Inc.'s Q4 2025 earnings?

The stock price moved up 0.08%, changed from $350.49 before the earnings release to $350.78 the day after.

When is Penumbra, Inc. expected to report next?

The next earning report is scheduled for Apr 21, 2026.

What are the forecasts for Penumbra, Inc.'s next earnings report?

Based on 17 analysts, Penumbra, Inc. is expected to report EPS of $1.08 and revenue of $374.82M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.